Search
Atovaquone is used to treat or prevent pneumocystis pneumonia, toxoplasmosis, malaria and babesiosis. Atovaquone inhibits the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket. In addition to its use as a treatment for toxoplasmosis, atovaquone has antimalarial properties and prevents pneumocystis pneumonia post-renal transplant.
| Items | Specifications | Results |
| Appearance | Yellow powder | Conforms |
| Assay | 97.5%~101.5% | 99.63% |
| Product parameters | |
| Cas number: | 95233-18-4 |
| Appearance: | Yellow powder |
| Purity: | 97.5~101.5% |
| Package details: | 10g/PE bottle;1kg/foil bag |
| Brand: | Fortunachem |

It is indicated for oral treatment of AIDS patients with mild to moderate Carne's pneumonia who cannot tolerate SMZ-TMP.

Fortunachem Provides Not Only Professional Chemical Products But Also Professional Help
Keeping you up-to-date with all the latest information, news, and events about Fortunachem!
Quick Links
Add:
E-mail:
English
Español
français
العربية